Background: Patients with idiopathic pulmonary fibrosis (IPF) often experience
Whether infection can induce AE-IPF remains elusive. Analyses using pan-viral microarray and multiplex polymerase chain reaction have found the common respiratory viruses in the respiratory track of patients with AE-IPF, such as cytomegalovirus, respiratory syncytial virus, parainfluenza virus, rhinovirus and coronavirus. 4, 5 A previous epidemiological study has shown that AE-IPF occurs frequently in winter and spring and in patients using immunosuppressants, 6 indicating that virus infection may be a critical factor contributing to AE-IPF. Studies using animal models have also demonstrated that mammal herpes virus γHV-68 infection in addition to lung fibrosis can exacerbate the lung fibrosis. 7, 8 However, animal models of infection-induced AE-IPF have not been established, which seriously limits the investigation on the biological mechanisms and therapeutic intervention of AE-IPF.
In our previous studies, we used twice intratracheal administration of bleomycin (BLM) to successfully establish a mouse model of noninfection-induced AE-IPF. 9, 10 We found that IL17A levels in the BALF of mice with BLM+BLM-induced AE-IPF were increased significantly compared with mice with stable BLM-induced IPF and intraperitoneal injection of anti-IL-17A antibody alleviated lung inflammation in the mice. 9 In the current study, we aim to use human herpes simplex virus modelled in the same way. Therefore, the lung tissues used for wet to dry ratios and histopathology were not perfused by saline.
| Lung tissue histopathological examination
After 24 hours of fixation, paraembedded lung tissue sections were prepared and used for H & E and Masson staining. The stained tissue sections were scanned by a Leica slide scanner (LEICA SCN400).
According to the report by Mikawa et al, 13 the acute lung injury (ALI) scores of the H&E staining tissue sections were determined.
The Masson staining score was determined following the criteria for CHEN ET AL.
| 909 the estimation of lung fibrosis severity developed by Ashcroft et al. 14 Two pathologists with extensive experience determined the ALI score and Masson staining score independently, and the average scores were used. 
| Survival curve

| Lung tissue wet/dry weight ratio
The wet weight of the middle lobe of the right lung was measured, and the dry weight was measured after the lung tissue was dried in a vacuum freeze dryer (LGJ-10D; Beijing Sihuan Company, Beijing, China) overnight. Wet/dry weight ratio = wet weight Ä dry weight. and β-actin. All the antibodies were purchased from Abcam. After the membrane was probed with secondary antibodies, the chemiluminescent signals were developed and the signal intensity was measured.
| Mouse lung function
| Statistical analyses
The statistical analysis software Graphpad prism6 was used for data analyses. Continuous variables are presented as mean ± standard deviation. Two-group comparison was analysed by independent sample t test. Multi-group comparison was analysed by one-way ANOVA and then Fisher's LSD test. The Kaplan-Merier method was used to plot survival curve, and the survival time was compared by the logrank test. P < 0.05 was considered statistically significant. Collagen deposition is in the peribronchial area and alveolar septum in both WT and IL-17A-/-mice. BLM or saline were administered intratracheally to mice, and 21 days after the BLM administration, saline or HSV1 solution was inoculated intranasally to the mice. On postHSV1-infection day 3 and day 7, mouse lung tissue was collected for H&E and Masson staining (n = 5 in each group). E, Mouse lung tissue fibrosis score. F, survival rate of WT and IL-17A-/-mice in the BLM+HSV1 and BLM+Saline groups. n = 14 in each group for survival observation. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. NS, not significant
survival rate of WT+BLM+HSV1 mice (21.4%, 3/14) was significantly lower than that of WT+BLM+Saline group (100%, 14/14, P < 0.0001, Figure 1F) . Notably, the survival rate of IL-17A -/-+BLM+HSV1 mice (11/14, 78.6%) was significantly higher than that of WT+BLM+HSV1 mice (P = 0.004, Figure 1F ).
The total protein in BALF in the BLM+HSV1group was significantly increased than that in the BLM+Saline group (Figure 2A) , and so was the lung tissue wet/dry weight ratio ( Figure 2B ). Compared with WT+BLM+HSV1 mice, IL-17A -/-+BLM+HSV1 mice had significantly reduced total protein in the BALF (P = 0.0358, Figure 2A ) and lung tissue wet/dry weight ratio ( Figure 2B ). These data indicate that HSV1 infection can cause lung oedema, alveolar epithelial damages and protein leakage from alveoli and that IL-17A -/-appear to attenuate the HSV1-stimulated adverse effects.
On post-HSV1 infection day 3, the FVC of the BLM+HSV1 group decreased significantly compared with that in the BLM+Saline group ( Figure 2C ), but Cdyn remained similar in the two groups (P = 0.4259, Figure 2D ). On post-HSV1 infection day 7, both FVC On day 24 (P = 0.0189) and day 28 (P = 0.0019), the total protein in BALF is significantly higher in the BLM+HSV1 group than in the BLM+Saline group. B, Lung tissue wet/dry weight ratio. On day 28, lung oedema is the most severe in the BLM+HSV1 group. The ratio is smaller in the IL-17A-/-+BLM+HSV1 group than in the WT+BLM+HSV1 group (P = 0.0051). C, FVC. On day 24 (P = 0.0177) and day 28 (P < 0.0001), FVC is lower in the BLM+HSV1 group than in the BLM+Saline group. FVC is higher in the IL-17A-/-+BLM+HSV1 group than in the WT+BLM+HSV1 group (P = 0.0054). D, Cdyn. On day 28, Cdyn is lower in the BLM+HSV1 group than in the BLM+Saline group (P = 0.0012) and is better in the IL-17A-/-+ BLM+HSV1 group than in the WT+BLM+HSV1 group (P = 0.0254). For the statistical analysis of lung function, n = 7 in each group. For other statistical analyses, n = 5 in each group. *P < 0.05. **P < 0.01. ***P < 0.001. ****P < 0.0001. NS, not significant; FVC, force vital capacity; Cdyn, dynamic pulmonary compliance the BLM+Saline group ( Figure 3D 
| HSV1 infection exacerbated endoplasmic reticulum stress (ERS) in fibrotic lung tissue
Endoplasmic reticulum stress (ERS) occurs commonly in the alveolar epithelial cells of patients with IPF. 15, 16 ERS-associated proteins were all overexpressed in the fibrotic lung tissues ( Figure 5A ). The BLM+Saline mice expressed significantly higher levels of ATF4 (P = 0.0018, Figure 5B ) and CHOP (P = 0.0223, Figure 5C ) in the lung tissues than the Saline+Saline mice. The BLM+HSV1 group F I G U R E 4 HSV1 infection in addition to BLM-induced lung fibrosis resulted in IL-17A-associated acute inflammation in the lung. A, IL-12/ 23p40. B, KC. C, IL-23. D, IL-6. E, IL-17A. F, G-CSF. Inflammatory factor concentration in BALF supernatants was analysed by liquid suspension array technology. IL-23 concentration was measured by ELISA. On day 24, compared with the BLM+Saline group, the BLM+HSV1 group shows significantly higher 12/23p40 (P = 0.0327, A) and KC (P = 0.0327, B). On day 28, compared with the BLM+Saline group, the BLM+HSV1 group shows significantly higher 12/23p40 (P = 0.0005, A), KC (P < 0.0001, B), IL-23 (P = 0.0014, C), IL-6 (P = 0.0017, D), IL-17A (P = 0.0067, E) and G-CSF (P = 0.0106, F). IL-17A-/-+BLM+HSV1 mice show significantly lower IL-12/23p40 (P = 0.0258, A), KC (P < 0.0001, B), IL-6 (P = 0.0188, D), IL-17A (P = 0.0001, E) and G-CSF (P = 0.0045, F) than WT+BLM+HSV1 mice. n = 5 in each group. *P < 0.05. **P < 0.01. ***P < 0.001. ****P < 0.0001. NS, not significant demonstrated significantly higher expression of ATF4 (P < 0.0001), CHOP (P = 0.0005) and ATF6 (P = 0.0257, Figure 5D ) than the BLM+Saline mice. TUDCA is an inhibitor of ERS. When we used TUDCA to treat BLM+HSV1 mice, the BLM+HSV1+TUDCA group expressed significantly lower levels of ATF-4 (P < 0.0001), CHOP (P = 0.0011) and ATF6 (P < 0.0001) than the BLM+HSV1 mice.
These data indicate that ERS may be activated in BLM-induced lung fibrosis and be further stimulated by HSV1 infection-induced AE-IPF and TUDCA can attenuated the ERS in AE-IPF model. Expressions of the three proteins in the BLM+HSV1 group are significantly higher than those in the other four groups. Saline or HSV1 solution was administered intranasally to the mice 21 days after the intratracheal administration of BLM, one group of BLM+HSV1 mice was administrated with TUDCA. On post-HSV1 infection day 7, protein was extracted from the lung tissues. Antimouse ATF4, CHOP, ATF6 and actin antibodies were used for immunoblotting assay. The protein signals were visualized by chemiluminescence. n = 4 in each group. *P < 0.05. **P < 0.01. ***P < 0.001. ****P < 0.0001. NS, not significant HSV1 virus, which can infect humans easily, to infect mice that already developed stable BLM-IPF. Our mouse model of AE-IPF can better mimic the AE-IPF development in patients.
Acute pulmonary inflammation is closely correlated with IL-17A. 19 IL-17A, a pro-inflammatory factor, is secreted predominantly by TH17
cells. IL-17A in lung tissues enhances inflammatory responses by
The ERS inhibitor TUDCA significantly attenuated BLM+HSV1-induced acute inflammation in the lung. A, Representative images of H&E staining of the BLM+HSV1+Saline and BLM+HSV1+TUDCA groups (100× magnification, scale bar = 200 μm). TUDCA treatment reduces inflammatory cell infiltration in lung tissue but does not affect the extent of lung fibrosis. B, ALI score. C, Masson staining. D, Fibrosis score. TUDCA treatment group shows lower ALI score than the control group (P = 0.0439) but similar fibrosis score. E, The numbers of different types of inflammatory cells in BALF. TUDCA treatment group has lower numbers of Neu & IM (P = 0.0451) than the control group. F, The proportion of TH1/TH17 in CD4+ T cells of peripheral blood. TUDCA treatment group shows significantly less TH17 cells (P = 0.0084). G and H. Inflammatory factor concentration in the BALF. TUDCA treatment reduces the concentrations of IL-23 (P = 0.0053), IL-6 (P = 0.0473), IL-17A (P = 0.0140), KC (P = 0.0041) and G-CSF (P = 0.0388). Saline or HSV1 solution was administered intranasally to the mice 21 days after they received the intratracheal administration of BLM. After the HSV1 infection, TUDCA (250 mg/kg) or saline was injected intraperitoneally daily for 7 days, and then lung tissue, blood and BALF were collected 7 days after the HSV1 infection. n = 5 in each group. Neu & IM: neutrophils and inflammatory monocytes. *P < 0.05. **P < 0.01. ***P < 0.001. ****P < 0.0001. NS, not significant promoting inflammatory monocyte and neutrophil chemotaxis so to clear pathogens effectively. 20 However, excessive inflammatory responses may damage tissue. 21 Both neutrophils and inflammatory monocytes are involved in pathogen elimination and can cause acute lung inflammation in an IL-17-dependent manner. 20 In the current study, the data indicates that IL-17A may not play an important role in driving lung fibrosis at day 28 in mice in response to bleomycin treatment ( Figure 1E ). This data seems to be in contradiction to the work by Wilson et al 22 17A in the innate primary immune responses. 24 In our preliminary study, we found that patients with AE-IPF had higher TH17 levels in peripheral blood than patients with stable-IPF (data not shown). Thus, in the current study, we focused on the roles of Th17 cells in the AE-IPF model. In our current study, we cannot exclude the effects of 31 In our study, ATF4 and ATF6 overexpression was quite obvious in the mice treated with BLM+HSV1. Jane and colleagues have found that CHOP can act as a transcription factor to co-ordinate NF-κB to stimulate IL-23p19 expression synergistically. 32 Our previous study has demonstrated that ERS occurs in AEC. In our previous study, we used alveolar epithelial cells (A549) to establish AE-IPF cell model, and found that HSV1 infection stimulated the ER stress pathways in AEC in a timeand dose-dependent manner. 11 In the current study, the mice treated with BLM+HSV1 had increased IL-23 levels in the BALF compared with the mice treated with BLM+Saline. IL-23 binds to the IL-23
receptor on naïve CD4 + T cells to induce the CD4 + T cells to differentiate into TH17 cells, consequently increasing IL-17A concentration. 33, 34 In addition, we found when ERS was inhibited by TUDCA, the proportion of Th17 cells in mouse peripheral blood was reduced;
IL17A concentration in BALF was decreased; acute lung injury was also attenuated. Our findings indicate that inhibition of ERS can alleviate lung inflammation, and it probably takes effects by reducing IL-17A production. However, a previous study on respiratory syncytial virus infection in animal models suggests that ERS in lung tissue increases IRE-1expression, resulting in caspase-1 cleavage and mature IL-1β production. This enhanced IL-1β secretion might account for the aggravation of inflammation. 35 While in a report on LPS-induced acute lung injury, ERS can activate NF-κB, 36 then it can promote kinds of cytokines' secretion, such as IL-6, IL-23, IL-17A, KC and G-CSF. Till now there has not been a study identifying which pathway plays a critical role, more work should be done to explore the relationship between ER stress and inflammation. In addition, the study also suggests that anti-IL-17A antibody treatment and IL-17A gene knockout alleviate UPR in lung tissue substantially, supporting that IL-17A may promote ERS in lung tissue 36 ( Figure 7 ).
| CONCLUSION S
This study successfully established HSV1 infection-induced AE-IPF in mice with BLM-induced lung fibrosis and found that IL-17A and ERS played key roles in the acute lung injury in AE-IPF. Our study provides an animal model of AE-IPF that highly mimic human AE-IPF to facilitate the investigation of the aetiology, pathogenic mechanism and intervention of AE-IPF.
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